News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
455,849 Results
Type
Article (28197)
Company Profile (70)
Press Release (427581)
Multimedia
Podcasts (108)
Webinars (12)
Section
Business (138468)
Career Advice (1570)
Deals (20754)
Drug Delivery (69)
Drug Development (50691)
Employer Resources (102)
FDA (10688)
Job Trends (9968)
News (224927)
Policy (21038)
Tag
Academia (1855)
Academic (2)
Accelerated approval (12)
Adcomms (13)
Allergies (93)
Alliances (37975)
ALS (124)
Alzheimer's disease (1191)
Antibody-drug conjugate (ADC) (207)
Approvals (10905)
Artificial intelligence (396)
Autoimmune disease (92)
Automation (30)
Bankruptcy (182)
Best Places to Work (8109)
BIOSECURE Act (7)
Biosimilars (123)
Biotechnology (47)
Bladder cancer (124)
Brain cancer (39)
Breast cancer (471)
Cancer (3579)
Cardiovascular disease (284)
Career advice (1357)
Career pathing (28)
CAR-T (180)
CDC (24)
Cell therapy (515)
Cervical cancer (31)
Clinical research (43572)
Collaboration (1290)
Company closure (3)
Compensation (526)
Complete response letters (23)
COVID-19 (1896)
CRISPR (72)
C-suite (501)
Cystic fibrosis (96)
Data (4719)
Decentralized trials (2)
Denatured (37)
Depression (76)
Diabetes (348)
Diagnostics (5343)
Digital health (33)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (188)
Drug pricing (93)
Drug shortages (22)
Duchenne muscular dystrophy (159)
Earnings (63500)
Editorial (41)
Employer branding (14)
Employer resources (88)
Events (68040)
Executive appointments (746)
FDA (12850)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (2)
Frontotemporal dementia (16)
Funding (1039)
Gene editing (146)
Generative AI (40)
Gene therapy (427)
GLP-1 (651)
Government (3041)
Grass and pollen (7)
Guidances (341)
Healthcare (11917)
HIV (40)
Huntington's disease (28)
IgA nephropathy (66)
Immunology and inflammation (161)
Immuno-oncology (24)
Indications (66)
Infectious disease (2071)
Inflammatory bowel disease (134)
Inflation Reduction Act (11)
Influenza (80)
Intellectual property (160)
Interviews (279)
IPO (9549)
IRA (30)
Job creations (2235)
Job search strategy (1124)
Kidney cancer (9)
Labor market (46)
Layoffs (274)
Leadership (27)
Legal (5070)
Liver cancer (57)
Longevity (9)
Lung cancer (531)
Lymphoma (282)
Machine learning (25)
Management (33)
Manufacturing (503)
MASH (121)
Medical device (8158)
Medtech (8182)
Mergers & acquisitions (11990)
Metabolic disorders (825)
Multiple sclerosis (115)
NASH (11)
Neurodegenerative disease (210)
Neuropsychiatric disorders (43)
Neuroscience (1992)
NextGen: Class of 2025 (4002)
Non-profit (3122)
Now hiring (23)
Obesity (347)
Opinion (198)
Ovarian cancer (98)
Pain (124)
Pancreatic cancer (138)
Parkinson's disease (190)
Partnered (20)
Patents (314)
Patient recruitment (270)
Peanut (38)
People (35552)
Pharmaceutical (18)
Pharmacy benefit managers (15)
Phase I (13314)
Phase II (18581)
Phase III (15277)
Pipeline (3235)
Policy (157)
Postmarket research (1869)
Preclinical (5991)
Press Release (49)
Prostate cancer (197)
Psychedelics (23)
Radiopharmaceuticals (175)
Rare diseases (540)
Real estate (3846)
Recruiting (40)
Regulatory (15707)
Reports (29)
Research institute (1760)
Resumes & cover letters (234)
Rett syndrome (22)
RNA editing (8)
RSV (48)
Schizophrenia (98)
Series A (170)
Series B (120)
Service/supplier (4)
Sickle cell disease (75)
Special edition (12)
Spinal muscular atrophy (112)
Sponsored (31)
Startups (1956)
State (2)
Stomach cancer (12)
Supply chain (69)
Tariffs (39)
The Weekly (70)
Vaccines (650)
Venture capital (37)
Weight loss (220)
Women's health (50)
Worklife (13)
Date
Today (3)
Last 7 days (531)
Last 30 days (1886)
Last 365 days (24051)
2025 (23419)
2024 (24393)
2023 (26051)
2022 (33923)
2021 (35938)
2020 (35325)
2019 (29850)
2018 (22309)
2017 (21410)
2016 (20915)
2015 (23903)
2014 (19709)
2013 (17108)
2012 (17280)
2011 (16983)
2010 (15770)
Location
Africa (623)
Alabama (65)
Alaska (5)
Arizona (142)
Arkansas (10)
Asia (26658)
Australia (4395)
California (7794)
Canada (2305)
China (743)
Colorado (350)
Connecticut (386)
Delaware (255)
Europe (62768)
Florida (1140)
Georgia (234)
Hawaii (2)
Idaho (41)
Illinois (603)
India (45)
Indiana (379)
Iowa (13)
Japan (309)
Kansas (81)
Kentucky (21)
Louisiana (12)
Maine (44)
Maryland (929)
Massachusetts (5799)
Michigan (223)
Minnesota (364)
Mississippi (2)
Missouri (102)
Montana (18)
Nebraska (13)
Nevada (97)
New Hampshire (41)
New Jersey (2315)
New Mexico (18)
New York (2149)
North Carolina (1019)
North Dakota (6)
Northern California (3690)
Ohio (227)
Oklahoma (16)
Oregon (22)
Pennsylvania (1532)
Puerto Rico (5)
Rhode Island (37)
South America (870)
South Carolina (30)
Southern California (3069)
Tennessee (139)
Texas (1222)
United States (28155)
Utah (240)
Vermont (1)
Virginia (181)
Washington D.C. (60)
Washington State (657)
West Virginia (3)
Wisconsin (93)
Wyoming (2)
455,849 Results for "g and w laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors
December 3, 2025
·
2 min read
Press Releases
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
November 13, 2025
·
1 min read
Press Releases
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
December 4, 2025
·
3 min read
Obesity
Protagonist Enters Obesity Fray With Triple-G Pill, Eyeing 2026 Clinical Start
With PN-477, Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II trial.
July 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
October 14, 2025
·
5 min read
Press Releases
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
December 12, 2025
·
2 min read
Press Releases
Vaxart Appoints W. Mark Watson as Lead Independent Director
September 18, 2025
·
6 min read
Press Releases
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
December 3, 2025
·
4 min read
Press Releases
Dr. William G. Kaelin Jr. joins IQVIA Board of Directors
November 5, 2025
·
3 min read
Press Releases
Charles River Laboratories to Present at Evercore Healthcare Conference
December 2, 2025
·
1 min read
1 of 45,585
Next
